Cytoseek

About:

For next-generation cell therapies.

Website: https://www.cytoseek.uk/

Twitter/X: CYTOSEEK

Top Investors: Future Planet Capital, SCVC, Parkwalk Advisors, UK Innovation & Science Seed Fund, Meltwind Advisory

Description:

CytoSeek's mission is to use cell membrane augmentation technology to unlock the potential of next generation of advanced therapies. We are a spinout company from the University of Bristol. Our novel cell membrane augmentation technology enables us to add new functionalities to cell therapies including tissue specific targeting and enhanced cell survivability. CytoSeek is engaged in proof of principle studies to demonstrate enhancement of cell therapies for cancer, heart disease, osteoarthritis and diabetic wound healing. We are looking to partner with cell therapy companies to bring these products to the clinic and ultimately enhance human health.

Total Funding Amount:

4.67M GBP

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Bristol, Bristol, City of, United Kingdom

Founded Date:

2017-01-01

Contact Email:

info(AT)cytoseek.uk

Founders:

Adam Perriman

Number of Employees:

1-10

Last Funding Date:

2021-03-16

IPO Status:

Private

Industries:

© 2025 bioDAO.ai